Φορτώνει......
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) is a promising tool to support the evaluation of response to either target therapies or immunotherapy with immune checkpoint inhibitors both in clinical trials and, in selected patients, at the single patient’s level. The present review aims to discuss...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Medicina (Kaunas) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466359/ https://ncbi.nlm.nih.gov/pubmed/32722205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina56080373 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|